April 19, 2026
2 min watch
MIAMI — In this video from Sunshine Eye & Retina, Nandini Venkateswaran, MD, discussed at a lunch symposium neurotrophic keratitis-targeted therapies to restore corneal sensation and repair vision.
Venkateswaran said physicians should test corneal sensation to understand corneal nerve health, how corneal hemostasis is affected by neurotrophic keratitis and why patients present with various degrees of corneal pathology.
“We have so many therapies we can now implement in our practices to treat these conditions, ranging from medical therapies to surgical interventions,” Venkateswaran, of Harvard Medical School and Massachusetts Eye and Ear, told Healio. “Cenegermin (Oxervate, Dompé) has been a mainstay in my clinical practice with the regrowth of corneal nerves on the surface of the eye, and we have other adjuncts, like autologous serum, platelet-rich plasma therapy and even upcoming new novel therapies that are currently in clinical trials that I think can expand our armamentarium for the treatment of this condition.”
Sources/Disclosures
Source:
Healio Interviews
Disclosures:
Venkateswaran reports consulting for Ocubio.
Ask a clinical question and tap into Healio AI’s knowledge base.
- PubMed, enrolling/recruiting trials, guidelines
- Clinical Guidance, Healio CME, FDA news
- Healio’s exclusive daily news coverage of clinical data
<
Leave a Reply